Enquyst Technologies Inc

Enquyst Technologies is an early-stage biotechnology company that is disrupting the way that biological drugs are manufactured. Enquyst Technologies is developing novel, modular equipment and processes to enable next-generation manufacturing of a diverse set of biological drug products, including, monoclonal antibodies (mAbs), bispecific antibodies, RNA therapeutics, plasmids, and viral vector technologies for gene therapy. Enquyst is developing its core, patented IPP technology to solve unmet needs in the downstream purification of viral vector gene therapies, specifically AAV and lentiviral products. Enquyst's IPP technology is expected to deliver a scalable, high purity solution to meet this unmet need.